Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

Approximately 75 % of extraskeletal myxoid chondrosarcoma tumors (EMC) harbor a t(9;22) chromosome translocation generating an EWS/NR4A3 fusion protein that is thought to be instrumental in the tumoral process. Current evidence suggests that one function of the fusion protein is to overexpress target genes. We have generated an in vitro human cellular model in which the fusion protein is expressed in mesenchymal bone marrow stem cells. We have performed microarray analyses of these cells and identified several genes overexpressed in the presence of EWS/NR4A3 which are also overexpressed in EMC tumors. These genes and their products represent potential therapeutic targets for EMC tumors.

Citation

Christine Filion, Yves Labelle. Identification of genes regulated by the EWS/NR4A3 fusion protein in extraskeletal myxoid chondrosarcoma. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 2012 Oct;33(5):1599-605

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 22592656

View Full Text